PROVIDER PROFILE · NPI 1275905606
Tyler BradyPA
PRESCRIBING · PART D · 2024
Total Rx claims
11
Beneficiaries
—
Total drug cost
$156
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Cefdinir11 claims
QUALITY · MIPS · 2024
Final MIPS score
87.3
Quality
89.5
Cost
71.7
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.52%
Group
CROSS-REFERENCE